UCL and UCLH to apply AI to tackle anti-microbial resistance

  25 June 2019

UCL and UCLH are set to apply artificial intelligence to tackle the global threat of anti-microbial resistance (AMR) after being awarded £3.3m in government funding.

Prof Judy Breuer at UCL will lead a team of researchers and clinicians at UCL, UCLH – including AMR expert at UCLH Prof Peter Wilson – and Great Ormond Street Hospital (GOSH) for the ‘Precision AMR (anti-microbial resistance)’ initiative to improve tests for antimicrobial resistance and to develop AI (artificial intelligence) algorithms to rapidly interpret test results.

They aim to enable earlier diagnosis and treatment with the right antibiotic; ensure treatment with the right dose and combination of drugs; and prevent the spread of antibiotic resistant infections.

Further reading: University College London
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!